Rockwell Medical Inc patents expiration
1. Triferic patents expiration
TRIFERIC Litigations
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6779468 | ROCKWELL MEDICAL INC | Method and pharmaceutical composition for iron delivery in hemodialysis and peritoneal dialysis patients |
Dec, 2016
(7 years ago) | |
| US6689275 | ROCKWELL MEDICAL INC | Method and pharmaceutical composition for replacing iron losses in dialysis patients |
Dec, 2016
(7 years ago) | |
| US7857977 | ROCKWELL MEDICAL INC | Packaging of ferric pyrophosphate for dialysis |
Sep, 2027
(3 years from now) | |
| US7816404 | ROCKWELL MEDICAL INC | Methods for the preparation and use of ferric pyrophosphate citrate chelate compositions |
Apr, 2029
(4 years from now) | |
Drugs and Companies using FERRIC PYROPHOSPHATE CITRATE ingredient
Market Authorisation Date: 23 January, 2015
Treatment: Method of iron administration to treat patients in need of iron replacement
Dosage: SOLUTION;INTRAVENOUS; POWDER;INTRAVENOUS
More Information on Dosage
TRIFERIC family patents
2. Triferic Avnu patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance. | ||||
| US7816404 | ROCKWELL MEDICAL INC | Methods for the preparation and use of ferric pyrophosphate citrate chelate compositions |
Apr, 2029
(4 years from now) | |
Drugs and Companies using FERRIC PYROPHOSPHATE CITRATE ingredient
Market Authorisation Date: 27 March, 2020
Treatment: Method of iron administration to treat patients in need of iron replacement therapy
Dosage: SOLUTION;INTRAVENOUS
More Information on Dosage
TRIFERIC AVNU family patents